Literature DB >> 3470904

Antibodies against lipopolysaccharide from Bacteroides gingivalis before and after periodontal treatment.

K Schenck, K Helgeland, T Tollefsen.   

Abstract

Specific serum antibody activities of the IgG, IgA and IgM isotypes against lipopolysaccharide (LPS) prepared from Bacteroides gingivalis were measured by an enzyme-linked immunosorbent assay (ELISA) in a group of 12 periodontally healthy subjects and a group of 26 patients with periodontitis. The latter group received periodontal therapy, completed within about 1 yr. A serum sample was obtained from each participant at the first periodontal examination; a second sample was taken about 2 yr later. The mean antibody levels calculated for the healthy group did not change significantly between the first and second examination. The correlation coefficients computed between the two sets of measurements were 0.93, 0.90 and 0.96 for IgG, IgM and IgA respectively (P less than 0.05). Periodontal treatment significantly improved the clinical status of the patients and was followed by a statistically significant mean reduction in specific antibody levels to the LPS preparation (IgG: 15%, IgA: 30% and IgM: 15%).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3470904     DOI: 10.1111/j.1600-0722.1987.tb01816.x

Source DB:  PubMed          Journal:  Scand J Dent Res        ISSN: 0029-845X


  6 in total

Review 1.  Periodontal disease immunology: 'double indemnity' in protecting the host.

Authors:  Jeffrey L Ebersole; Dolphus R Dawson; Lorri A Morford; Rebecca Peyyala; Craig S Miller; Octavio A Gonzaléz
Journal:  Periodontol 2000       Date:  2013-06       Impact factor: 7.589

2.  Serodiagnosis of Porphyromonas gingivalis infection by immunoblot analysis with recombinant collagenase.

Authors:  M Wittstock; T F Flemmig; H Schmidt; R Mutters; H Karch
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

3.  Initial serum antibody titer to Porphyromonas gingivalis influences development of antibody avidity and success of therapy for chronic periodontitis.

Authors:  J Mooney; E Adonogianaki; M P Riggio; K Takahashi; A Haerian; D F Kinane
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

4.  Humoral responses to Porphyromonas gingivalis gingipain adhesin domains in subjects with chronic periodontitis.

Authors:  Ky-Anh Nguyen; Arthur A DeCarlo; Mayuri Paramaesvaran; Charles A Collyer; David B Langley; Neil Hunter
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

5.  Porphyromonas gingivalis virulence in mice: induction of immunity to bacterial components.

Authors:  L Kesavalu; J L Ebersole; R L Machen; S C Holt
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

6.  Correlation of salivary immunoglobulin A against lipopolysaccharide of Porphyromonas gingivalis with clinical periodontal parameters.

Authors:  Pushpa S Pudakalkatti; Abhinav S Baheti
Journal:  Contemp Clin Dent       Date:  2015 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.